CVS Health (NYSE:CVS – Get Free Report) and P3 Health Partners (NASDAQ:PIII – Get Free Report) are both healthcare companies, but which is the better investment? We will contrast the two companies based on the strength of their earnings, valuation, profitability, institutional ownership, analyst recommendations, dividends and risk.
Volatility and Risk
CVS Health has a beta of 0.58, meaning that its stock price is 42% less volatile than the S&P 500. Comparatively, P3 Health Partners has a beta of 1.81, meaning that its stock price is 81% more volatile than the S&P 500.
Insider & Institutional Ownership
80.7% of CVS Health shares are owned by institutional investors. Comparatively, 7.7% of P3 Health Partners shares are owned by institutional investors. 0.9% of CVS Health shares are owned by insiders. Comparatively, 10.9% of P3 Health Partners shares are owned by insiders. Strong institutional ownership is an indication that endowments, hedge funds and large money managers believe a company will outperform the market over the long term.
Valuation & Earnings
This table compares CVS Health and P3 Health Partners”s revenue, earnings per share and valuation.
| Gross Revenue | Price/Sales Ratio | Net Income | Earnings Per Share | Price/Earnings Ratio | |
| CVS Health | $402.07 billion | 0.28 | $1.77 billion | $8.59 | 10.40 |
| P3 Health Partners | $1.46 billion | 0.01 | -$147.95 million | ($23.26) | -0.12 |
CVS Health has higher revenue and earnings than P3 Health Partners. P3 Health Partners is trading at a lower price-to-earnings ratio than CVS Health, indicating that it is currently the more affordable of the two stocks.
Profitability
This table compares CVS Health and P3 Health Partners’ net margins, return on equity and return on assets.
| Net Margins | Return on Equity | Return on Assets | |
| CVS Health | 2.62% | 13.65% | 4.20% |
| P3 Health Partners | -3.30% | N/A | -9.38% |
Analyst Recommendations
This is a summary of current ratings for CVS Health and P3 Health Partners, as reported by MarketBeat.com.
| Sell Ratings | Hold Ratings | Buy Ratings | Strong Buy Ratings | Rating Score | |
| CVS Health | 0 | 2 | 23 | 0 | 2.92 |
| P3 Health Partners | 1 | 2 | 1 | 0 | 2.00 |
CVS Health currently has a consensus target price of $107.54, indicating a potential upside of 20.34%. P3 Health Partners has a consensus target price of $13.67, indicating a potential upside of 406.17%. Given P3 Health Partners’ higher possible upside, analysts plainly believe P3 Health Partners is more favorable than CVS Health.
Summary
CVS Health beats P3 Health Partners on 10 of the 13 factors compared between the two stocks.
About CVS Health
CVS Health is a U.S.-based health care company that operates retail pharmacies, provides pharmacy benefit management services, and offers health insurance and other health services. Its businesses include CVS Pharmacy, pharmacy benefit manager CVS Caremark, and Aetna, its health benefits division. The company also provides care through MinuteClinic walk-in clinics and health care businesses including Oak Street Health and Signify Health. Its services span prescription fulfillment, pharmacy benefit management, health insurance, primary care, and in-home and community-based care.
About P3 Health Partners
P3 Health Partners is a physician-led healthcare company focused on helping independent physicians deliver coordinated, value-based care. Its model emphasizes preventive care and managing patients’ overall health, particularly for people enrolled in Medicare Advantage plans. The company supports participating providers with care coordination, data and technology, clinical resources, and administrative services. It also works with health plans under value-based arrangements, in which care is organized around patient outcomes and quality rather than solely the volume of services provided.
Receive News & Ratings for CVS Health Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for CVS Health and related companies with MarketBeat.com's FREE daily email newsletter.
